Barbara Marriage

Dr. Barbara Marriage


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
BMBarbara Marriage
Barbara Marriage
RBRachael H. Buck
Rachael H. Buck
KGKaren C. Goehring
Karen C. Goehring
JOJeffery S. Oliver
Jeffery S. Oliver
JWJennifer A. Williams
Jennifer A. Williams
Objectives: The aim of the present study was to examine the growth and tolerance of infants fed infant formulas with a caloric density closer to human milk (HM) supplemented with human milk oligosaccharides (HMOs) and to study uptake of the HMOs.Methods: A prospective, randomized, controlled, growth and tolerance study was conducted in healthy, singleton infants (birth weight ≥2490 g), who were enrolled by day of life (DOL) 5. Formula‐fed infants were randomized to 1 of 3 formulas with a caloric density of 64.3 kcal/dL. Each formula contained galactooligosaccharides, and the 2 experimental formulas contained varying levels (0.2 and 1.0 g/L) of the HMO 2′‐fucosyllactose (2′FL). The 3 formula groups were compared with an HM‐fed reference group. Infants were exclusively fed either formula (n = 189) or HM (n = 65) from enrollment to 119 DOL. 2′FL was measured in the blood and urine collected from a subset of infants at DOL 42 and 119, and in HM collected from breast‐feeding mothers at DOL 42.Results: There were no significant differences among any groups for weight, length, or head circumference growth during the 4‐month study period. All of the formulas were well tolerated and comparable for average stool consistency, number of stools per day, and percent of feedings associated with spitting up or vomit. 2′FL was present in the plasma and urine of infants fed 2′FL, and there were no significant differences in 2′FL uptake relative to the concentration fed.Conclusions: This is the first report of infants fed 2′FL‐fortified formulas with a caloric density similar to HM. Growth and 2′FL uptake were similar to those of HM‐fed infants.

1 January 2012 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
SHShelly N. Hester
Shelly N. Hester
DHDeborah S. Hustead
Deborah S. Hustead
AMAmy D. Mackey
Amy D. Mackey
ASAtul Singhal
Atul Singhal
BMBarbara Marriage
Barbara Marriage
Faster weight gain early in infancy may contribute to a greater risk of later obesity in formula-fed compared to breast-fed infants. One potential explanation for the difference in weight gain is higher macronutrient intake in formula-fed infants during the first weeks of life. A systematic review was conducted using Medline to assess the macronutrient and energy content plus volume of intake in breast-fed and formula-fed infants in early infancy. All studies from healthy, term, singleton infants reporting values for the composition of breast milk during the first month of life were included. The energy content of colostrum (mean, SEM:53.6±2.5 kcal/100 mL), transitional milk (57.7±4.2 kcal/100 mL), and mature milk (65.2±1.1 kcal/100 mL) was lower than conventional infant formula (67 kcal/100 mL) on all days analyzed. The protein concentration of colostrum (2.5±0.2 g/100 mL) and transitional milk (1.7±0.1 g/100 mL) was higher than formula (1.4 g/100 mL), while the protein content of mature milk (1.3±0.1 g/100 mL) was slightly lower. Formula-fed infants consume a higher volume and more energy dense milk in early life leading to faster growth which could potentially program a greater risk of long-term obesity.

1 August 2003 in Journal of the American Dietetic Association
Verified
Journal Article
Closed access
BMBarbara Marriage
Barbara Marriage
MCM.THomas Clandinin
M.THomas Clandinin
DGD.MOira Glerum
D.MOira Glerum

1 April 2004 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
BMBarbara Marriage
Barbara Marriage
MCM.THomas Clandinin
M.THomas Clandinin
IMIan Murdoch MacDonald
Ian Murdoch MacDonald
DGD.MOira Glerum
D.MOira Glerum

9 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlett RamirezCarlett Ramirez
Carlett Ramirez
MBMaria Geraldine E. Baggs
Maria Geraldine E. Baggs
BMBarbara Marriage
Barbara Marriage
Background: The purpose of this study was to evaluate the growth, tolerance and compliance effects of an extensively hydrolyzed formula with added 2′-FL in an intended use population of infants. Methods: A non-randomized, single-group, multicenter study was conducted. Infants (0–60 days of age) with suspected food protein allergy, persistent feeding intolerance, or presenting conditions where an extensively hydrolyzed formula (eHF) was deemed appropriate were enrolled in a 2-month feeding trial. The primary outcome was maintenance of weight for age z-score during the study. Weight, length, head circumference, formula intake, tolerance measures, clinical symptoms and questionnaires were collected. Forty-eight infants were enrolled and 36 completed the study. Results: Weight for age z-scores of infants showed a statistically significant improvement from study day 1 to study day 60 (0.32 ± 0.11, p = 0.0078). Conclusions: Overall, the results of the study demonstrate that the study formula was well tolerated, safe and supported growth in the intended population.

20 November 2017 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
BMBarbara Marriage
Barbara Marriage
JWJennifer A. Williams
Jennifer A. Williams
YCYong S. Choe
Yong S. Choe
KMKevin C. Maki
Kevin C. Maki
MVMustafa Vurma
Mustafa Vurma
SDStephen J. DeMichele
Stephen J. DeMichele
With the association between increased carotenoid intake and lower risk of chronic diseases, the absorption of lutein from the diet becomes an important factor in its delivery and physiological action. The primary objective of this study was to gain an understanding of how a new formulation technology (mixture of mono- and diglycerides (MDG)), affected lutein absorption. Subjects (n24) were randomised in a cross-over, double-blind study to receive a single dose of 6 mg lutein (FloraGLO 20 %) provided as capsules containing either high-oleic safflower (SAF) oil or a MDG oil. Subjects receiving a single dose of lutein in MDG showed a significantly greater change from baseline (0 h) to 4, 6, 8, 12, 24, 48 and 336 h (P<0·05) and baseline adjusted AUC for plasma lutein at 48 and 336 h (P<0·001) as compared with subjects given lutein in SAF. Analysis of the 48 h absorption kinetics of lutein showed that the time to peak level of lutein (12 h) was the same for SAF and MDG groups, but the change in plasma lutein at 12 and 48 h were 129 and 320 % higher, respectively, for MDG compared with SAF. This difference continued as the adjusted AUC 0–48 and 0–336 h for the MDG group was 232 and 900 % higher, respectively, v. SAF. The study data show that by changing the lipid that is combined with a lutein supplement results in significant increases in lutein absorption in healthy adults.